Results 111 to 120 of about 20,522 (204)

Multiply doses of FDC of rosuvastatin and ezetimibe versus rosuvastatin monotherapy in Chinese patients with hypercholesterolemia (ROSE-CH): multicenter, randomized-controlled trial

open access: yesLipids in Health and Disease
Objective Rosuvastatin plus ezetimibe improves the lipid-lowering effect through different mechanisms of action. This study intended to compare the efficacy and safety of the fixed-dose combination (FDC) of rosuvastatin/ezetimibe vs.
Xianyou Ji   +35 more
doaj   +1 more source

Ezetimibe and vascular endothelial function. [PDF]

open access: yes
Hypercholesterolemia is a major risk factor for cardiovascular diseases that has been managed mostly with 3-hydroxy-3-methyl glutaryl coenzyme A reductase inhibitors (statins) that suppress de novo cholesterol synthesis in the liver.
Maemura, Koji, Ikeda, Satoshi
core  

Pengembangan Sistem Dispersi Padat Ezetimibe dengan Matriks PEG 8000 menggunakan Metode Peleburan [PDF]

open access: yes
Ezetimibe termasuk pada Biopharmaceutics Classification Sistem (BCS) kelas II yang memiliki kelarutan yang rendah, sehingga laju disolusi dan bioavailabilitas oralnya rendah.
Rahayyu, Annisa Maulidia
core  

FIXED COMBINATION ATORVASTATIN-EZETIMIBE (ATOZET(R))

open access: yes, 2016
peer reviewedCardiovascular prevention in subjects at high or very high risk requires a drastic reduction in LDL cholesterol according to the concept "the lower, the better".
Scheen, André
core  

Comparative biomarker efficacy of cholesteryl ester transfer protein inhibitors: a network meta-analysis. [PDF]

open access: yesEur Heart J Cardiovasc Pharmacother
Banach M   +10 more
europepmc   +1 more source

Optimizing Cardiovascular Risk in PLWH: Real-World Efficacy and Lipid Kinetics of Fixed-Dose Combination Rosuvastatin Ezetimibe. [PDF]

open access: yesInfect Dis Rep
Falasca K   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy